The value of systematic lymph node dissection for intrahepatic cholangiocarcinoma from the viewpoint of liver lymphatics

被引:0
作者
Yuji Morine
Mitsuo Shimada
机构
[1] Institute of Health Biosciences,Department of Surgery
[2] The University of Tokushima Graduate School,undefined
来源
Journal of Gastroenterology | 2015年 / 50卷
关键词
Intrahepatic cholangiocarcinoma; Lymphatic system; Lymph node metastasis; Lymph node dissection;
D O I
暂无
中图分类号
学科分类号
摘要
Lymph node (LN) metastasis from intrahepatic cholangiocarcinoma (IHCC) might be one of the most important indicators of aggressive surgical resection, yet the value of LN dissection is still controversial. To address this clinical problem, we need to better understand the multidirectional lymphatic outflow from the liver. Although most hepatic lymph flows into the hilar LNs along portal triads, there are also several lymphatic outflows directly communicating with distant areas or the general lymphatic system. Moreover, it has been revealed that LN metastasis spreads to more distal LNs through the hepatoduodenal ligament or other multidirectional lymphatic pathways connected to the general lymphatic system. Therefore, systematic LN dissection might merely be LN sampling in IHCC with LN metastasis. A multidisciplinary strategy focusing on adjuvant treatment after surgery is immediately necessary in these cases. In IHCC without LN metastasis, the accuracy of preoperative imaging assessment of LN metastasis is unsatisfactory and useless for detecting metastatic LNs in clinical settings. Therefore, prophylactic systematic LN dissection for IHCC without preoperative LN swelling is recommended for accurate LN status assessment and reduction of local recurrences. However, this procedure might not offer any clinical benefit according to the results of retrospective comparative studies. In this review, we summarize previous reports regarding lymphatic outflow of the liver and discuss LN dissection for IHCC.
引用
收藏
页码:913 / 927
页数:14
相关论文
共 208 条
[1]  
Ikai I(2007)Report of the 17th nationwide follow-up survey of primary liver cancer in Japan Hepatol Res 37 676-691
[2]  
Arii S(2008)Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection Ann Surg 248 84-96
[3]  
Okazaki M(2013)Intrahepatic cholangiocarcinoma: management options and emerging therapies J Am Coll Surg 217 736-750
[4]  
Endo I(1997)Hepatic resection and transplantation for peripheral cholangiocarcinoma J Am Coll Surg 185 429-436
[5]  
Gonen M(1995)Aggressive surgical resection for cholangiocarcinoma Arch Surg 130 270-276
[6]  
Yopp AC(1998)Aggressive surgical treatment of intrahepatic cholangiocarcinoma: predictors of outcomes J Am Coll Sug 187 365-372
[7]  
Dodson RM(1999)Clinicopathological features and outcome of hepatic resection for intrahepatic cholangiocarcinoma in Japan J Hepatobiliary Pancreato Surg 6 108-116
[8]  
Weiss MJ(1988)Incidence, etiologic aspects and clinicopathological features in intrahepatic cholangiocaltinoma—a study of 51 cases from a low endemicity area Acta Oncol m37 77-83
[9]  
Cosgrove D(1997)Intrahepatic cholangiocarcinoma World J Surg 21 301-306
[10]  
Casavila FA(2003)Extended hepatic resection and outcomes in intrahepatic cholangiocarcinoma J Hepatobiliary Pancreat Surg 10 259-264